Advertisement

In a letter to shareholders InVivo Therapeutics Holdings Corp.(NVIV) CEO Frank Reyolds said he believes InVivo’s stock is undervalued and blames the 50 percent decline since the end of August on “unsubstantiated” Internet rumors which claimed Reynolds had sold shares in recent months.

Advertisement
Advertisement